{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:45:23Z","timestamp":1791747923089,"version":"4.3.4"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T00:00:00Z","timestamp":1365379200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0060969","type":"journal-article","created":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T21:03:29Z","timestamp":1365455009000},"page":"e60969","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["StreptInCor: A Candidate Vaccine Epitope against S. pyogenes Infections Induces Protection in Outbred Mice"],"prefix":"10.1371","volume":"8","author":[{"given":"Edilberto","family":"Postol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Alencar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio T.","family":"Higa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Freschi de Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea M. F.","family":"Demarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Kalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza","family":"Guilherme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tim.2007.05.001","article-title":"New understanding of the group A Streptococcus pathogenesis cycle","volume":"15","author":"AH Tart","year":"2007","journal-title":"Trends Microbiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"JR Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"ref3","first-page":"3","article-title":"[Brazilian guidelines for the diagnosis, treatment and prevention of rheumatic fever]","volume":"93(3","author":"Cardiologia Sociedade Brasileira de","year":"2009","journal-title":"Arq Bras Cardiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1542\/peds.96.4.758","article-title":"Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association","volume":"96","author":"A Dajani","year":"1995","journal-title":"Pediatrics"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.ijporl.2007.06.006","article-title":"Overcoming penicillin failures in the treatment of Group A streptococcal pharyngo-tonsillitis","volume":"71","author":"I Brook","year":"2007","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1086\/444505","article-title":"Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles\u2013report of a National Institute of Allergy and Infectious Diseases workshop","volume":"41","author":"AL Bisno","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/scientificamerican0691-58","article-title":"Streptococcal M protein","volume":"264","author":"VA Fischetti","year":"1991","journal-title":"Sci Am"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jama.292.6.709","article-title":"Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial","volume":"292","author":"KL Kotloff","year":"2004","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/444458","article-title":"Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers","volume":"41","author":"SA McNeil","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2011.09.005","article-title":"New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci","volume":"29","author":"JB Dale","year":"2011","journal-title":"Vaccine"},{"key":"ref11","first-page":"1945","article-title":"Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A. J Exp Med","volume":"167","author":"D Bessen","year":"1988"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1128\/IAI.73.4.2360-2366.2005","article-title":"Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine","volume":"73","author":"KL Kotloff","year":"2005","journal-title":"Infect Immun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1086\/466528","article-title":"Toward the development of an antidisease, transmission-blocking intranasal vaccine for group a streptococcus","volume":"192","author":"MR Batzloff","year":"2005","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.vaccine.2005.01.041","article-title":"Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides","volume":"23","author":"C Olive","year":"2005","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.resmic.2004.12.009","article-title":"M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats","volume":"156","author":"H Vohra","year":"2005","journal-title":"Res Microbiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.vaccine.2006.11.031","article-title":"Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein\/SfbI lipid core peptide vaccine formulation","volume":"25","author":"C Olive","year":"2007","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/CMR.13.3.470-511.2000","article-title":"Pathogenesis of group A streptococcal infections","volume":"13","author":"MW Cunningham","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10875-009-9332-6","article-title":"Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease","volume":"30","author":"L Guilherme","year":"2010","journal-title":"J Clin Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0974-2069.79617","article-title":"Genes, autoimmunity and pathogenesis of rheumatic heart disease","volume":"4","author":"L Guilherme","year":"2011","journal-title":"Ann Pediatr Cardiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/17402520600877026","article-title":"Towards a vaccine against rheumatic fever","volume":"13","author":"L Guilherme","year":"2006","journal-title":"Clin Dev Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ymeth.2009.03.024","article-title":"A vaccine against S. pyogenes: design and experimental immune response","volume":"49","author":"L Guilherme","year":"2009","journal-title":"Methods"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.1074\/jbc.M110.132118","article-title":"Anti-group A streptococcal vaccine epitope: structure, stability, and its ability to interact with HLA class II molecules","volume":"286","author":"L Guilherme","year":"2011","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1016\/j.vaccine.2011.08.113","article-title":"HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate","volume":"29","author":"MT Guerino","year":"2011","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-0484","article-title":"Burden and economic cost of group A streptococcal pharyngitis","volume":"121","author":"E Pfoh","year":"2008","journal-title":"Pediatrics"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1542\/peds.2006-3368","article-title":"Burden of acute sore throat and group A streptococcal pharyngitis in school-aged children and their families in Australia","volume":"120","author":"MH Danchin","year":"2007","journal-title":"Pediatrics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1440-1754.2008.01384.x","article-title":"Epidemiology of acute rheumatic fever in New Zealand 1996\u20132005","volume":"44","author":"R Jaine","year":"2008","journal-title":"J Paediatr Child Health"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MAJ.0b013e3181e939ab","article-title":"Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections","volume":"340","author":"MS Bronze","year":"2010","journal-title":"Am J Med Sci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1073\/pnas.96.18.10338","article-title":"Mice lacking all conventional MHC class II genes","volume":"96","author":"L Madsen","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","article-title":"Aluminium compounds for use in vaccines","volume":"82","author":"EB Lindblad","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1126\/science.1089926","article-title":"Promotion of B cell immune responses via an alum-induced myeloid cell population","volume":"304","author":"MB Jordan","year":"2004","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/B978-0-12-385855-9.00002-3","article-title":"Rheumatic heart disease: mediation by complex immune events","volume":"53","author":"L Guilherme","year":"2011","journal-title":"Adv Clin Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1128\/IAI.66.9.4418-4424.1998","article-title":"Immunological relationship between the class I epitope of streptococcal M protein and myosin","volume":"66","author":"A Quinn","year":"1998","journal-title":"Infect Immun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0002-9440(10)61665-3","article-title":"Cardiac myosin and the TH1\/TH2 paradigm in autoimmune myocarditis","volume":"159","author":"MW Cunningham","year":"2001","journal-title":"Am J Pathol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.molimm.2003.11.023","article-title":"T cell mimicry in inflammatory heart disease","volume":"40","author":"MW Cunningham","year":"2004","journal-title":"Mol Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.4049\/jimmunol.176.9.5662","article-title":"Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease","volume":"176","author":"KC Fa\u00e9","year":"2006","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1371\/journal.pone.0000010","article-title":"Differences between Belgian and Brazilian group A Streptococcus epidemiologic landscape","volume":"1","author":"PR Smeesters","year":"2006","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1016\/j.vaccine.2008.08.037","article-title":"Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development","volume":"26","author":"PR Smeesters","year":"2008","journal-title":"Vaccine"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/521264","article-title":"The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000\u20132004","volume":"45","author":"RE O\u2019Loughlin","year":"2007","journal-title":"Clin Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0060969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T09:34:32Z","timestamp":1644744872000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0060969"}},"subtitle":[],"editor":[{"given":"Michael S.","family":"Chaussee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,8]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0060969","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,8]]}}}